
NEOGEN CORP
Nasdaq · In Vitro & In Vivo Diagnostic Substances
Company Overview
A concise company profile alongside the latest public filing activity.
Neogen Corp develops, manufactures, and markets products used to detect food and animal safety risks, including diagnostic test kits for food-borne pathogens, toxins, allergens, and animal health conditions, as well as veterinary instruments and genomics testing services.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Nassif MikhealCEO | Buy | $6K | 505at $11.95 | Oct 9, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable NEOG activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.